MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Hyperkinesia associated with tuberculous meningitis in children: report of 2 cases.

    I. Estrada-Bellmann, E. Villarreal-Garza, C. Torres-González, B. Chávez-Luévanos, A. Cantú-Salinas, S. Castillo-Torres (Monterrey, Mexico)

    Objective: We present two pediatric patients with normal neurodevelopment, and incomplete vaccination schedule due to lack of BCG vaccine, who developed hyperkinesias secondary to tuberculous…
  • 2022 International Congress

    ‘A study of seven patients with Hemimasticatory spasm; barriers to treatment and outcomes of botulinum toxin’

    A. Aundhakar, A. Nanavati, B. Mishal, P. Wadia (Mumbai, India)

    Objective: To assess barriers to treatment and outcomes of botulinum toxin in patients treated for Hemimasticatory spasm Background: Hemimasticatory spasm (HMS) is a rare peripherally induced…
  • 2022 International Congress

    Correlation between H-ABC and thyroid hormones signaling in the process of adult neurogenesis

    A. Lopez-Juarez, V. Hernandez, D. Carmona (Leon, Mexico)

    Objective: To analyze a possible correlation between the TH signaling and cellular fate of adult neural stem cells on taiep rats. Background: H-ABC is a…
  • 2022 International Congress

    CCDC88C p.R464H likely cause a novel late-onset parkinsonism phenotype

    Z. Lin, W. Luo (Hangzhou, China)

    Objective: We describe two sisters with late-onset parkinsonism associated with a CCDC88C variant (p.R464H). Background: Tsoi et al. (2014) identified a heterozygous missense mutation in the CCDC88C gene (R464H), by…
  • 2022 International Congress

    A Literature Review: Effectiveness of Transcranial Direct Current Stimulation on gait speed and freezing of gait in patients with Parkinson’s disease

    T. Mok (hong kong, Hong Kong)

    Objective: The objective of this review is to update evidence on benefits of tDCS on gait speed and freezing of gait (FOG) for PD patients…
  • 2022 International Congress

    Cerebellar sodium disequilibrium in a patient with ATP1A3-related rapid onset dystonia-parkinsonism

    J. Prasuhn, M. Göttlich, S. Großer, K. Reuther, B. Ebeling, A. Münchau, A. Nagel, N. Brüggemann (Lübeck, Germany)

    Objective: Here, we applied non-invasive 23Na Magnetic Resonance Imaging to study pathophysiology-related changes in the total and intracellular sodium content in a patient with rapid-onset…
  • 2022 International Congress

    Prevention and management of Deep Brain Stimulation (DBS) surgical site infections (SSI) – multicentre survey of UK practice.

    S. Perides, J. Candelario-Mckeown, M. Kaminska, H. Hasegawa (London, United Kingdom)

    Objective: The aim of this survey was to better understand trends, patterns and practices of DBS surgical site care in the UK. Background: Deep brain…
  • 2022 International Congress

    Alien hand syndrome in ischemic stroke: a case-report

    K. Manysheva (Makhachkala, Russian Federation)

    Objective: Alien hand syndrome (AHS) is a rare movement disorder that inspires fear to patients and confuses doctors. So we describe a rare case-report. Background:…
  • 2022 International Congress

    The Journey Of Levodopa Treatment in Parkinson’s disease

    B. Pandey (Tirupati, India)

    Objective: This study aims to relook the journey of levodopa in the treatment of Parkinson’s disease. Background: Levodopa has been used in the treatment of…
  • 2022 International Congress

    Bitopertin, a GlyT1 inhibitor, attenuates the development of dyskinesia in the 6-OHDA-lesioned rat

    I. Frouni, W. Kang, D. Bédard, S. Belliveau, C. Kwan, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To evaluate the effect of the glycine transporter 1 (GlyT1) inhibitor bitopertin at preventing dyskinesia development in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson’s…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley